Molecular size characterization of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines
- 30 April 1996
- Vol. 14 (5) , 399-404
- https://doi.org/10.1016/0264-410x(95)00202-c
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Efficacy of Haemophilus influenzae type B conjugate vaccine in Oxford regionThe Lancet, 1992
- Finnish Efficacy Trials with Haemophilus influenzae Type b VaccinesThe Journal of Infectious Diseases, 1992
- Polysaccharide-protein conjugate vaccines for the prevention of Haemophilus influenzae type b diseaseThe Journal of Pediatrics, 1988
- Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old childrenThe Journal of Pediatrics, 1988
- Efficacy ofHaemophilus IinfluenzaeType b Polysaccharide–Diphtheria Toxoid Conjugate Vaccine in InfancyNew England Journal of Medicine, 1987
- IMMUNOGENICITY IN INFANTS OF HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE IN A CONJUGATE VACCINE WITH NEISSERIA MENINGITIDIS OUTER-MEMBRANE PROTEINThe Lancet, 1986
- Vaccine prevention of Haemophilus influenzae type b diseaseThe Pediatric Infectious Disease Journal, 1986
- Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates.The Journal of Experimental Medicine, 1980
- Quantitative Measurement of “Natural” and Immunization-induced Haemophilus influenzas type b Capsular Polysaccharide AntibodiesPediatric Research, 1973
- Immunization of Humans with Polyribophosphate, the Capsular Antigen of Hemophilus influenzae, Type bJournal of Clinical Investigation, 1972